ryodipine has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubur, GJ; Gendvilienè, VI; Kimenis, AA; Macianskiene, RA; Narusevicius, EV; Selga, MJ; Simkhovich, BZ; Velena, AH; Vitolina, RO; Zarinsh, GV | 1 |
| Naumov, VG; Naumova, NA; Shkarin, VV | 1 |
1 trial(s) available for ryodipine and cardiovascular agents
| Article | Year |
|---|---|
[The prognosis of the antianginal effect of foridon compared to other antianginal preparations].
Topics: Angina Pectoris; Blood Pressure; Cardiovascular Agents; Echocardiography; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Nifedipine; Prognosis; Respiratory Function Tests | 1993 |
1 other study(ies) available for ryodipine and cardiovascular agents
| Article | Year |
|---|---|
Effect of ryodipine on electromechanical parameters of heart and vessels, cAMP phosphodiesterase activity and swelling-contraction cycle of mitochondria.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anura; Calcium Channel Blockers; Cardiovascular Agents; Cattle; Dihydropyridines; Electric Stimulation; Electrophysiology; Heart; In Vitro Techniques; Mitochondria; Mitochondria, Liver; Mitochondrial Swelling; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Nicardipine; Nifedipine; Pyridines; Rabbits; Rats | 1985 |